Malaria Detection: A New LAMP Test for Travelers
"Discover how a commercial LAMP test offers a faster, more accurate way to rule out malaria in returning travelers, reducing healthcare costs and improving patient care."
Malaria, a disease affecting millions worldwide, demands accurate and timely diagnosis. Traditionally, healthcare providers have relied on microscopy and rapid diagnostic tests (RDTs). However, these methods have limitations, especially in non-endemic areas like North America, where the vast majority of tests come back negative.
A new study published in Open Forum Infectious Diseases explores the potential of loop-mediated isothermal amplification (LAMP) assays to improve malaria detection in returning travelers. This prospective diagnostic trial, conducted between June 2017 and January 2018, compares the Meridian illumigene Malaria assay with conventional microscopy and RDTs, offering a promising alternative for ruling out malaria with greater accuracy and efficiency.
The study enrolled 298 patients presenting with malaria-like symptoms. Researchers sought to evaluate the clinical performance of the LAMP test against microscopy and RDTs. The findings highlight the LAMP assay's potential to transform malaria diagnostics, offering a faster, more sensitive method for healthcare providers.
The Global Malaria Burden
Malaria transmission occurs in 80 countries across five WHO regions, and globally in 2024 the number of deaths was estimated at 610,000, with a mortality rate of 13.8 per 100,000 population at risk. The disease remains life-threatening, with symptoms including chills, fever, vomiting, diarrhea, and jaundice, though it can be treated with drugs when diagnosed via blood test. The malaria diagnostics market generated USD 729.10 million in revenue in 2023 and is projected to reach USD 896.33 million by 2033, expanding at a CAGR of 2.2%.
Microscopy, RDTs, and Molecular Techniques
Microscopy remains the gold standard for malaria diagnosis, though it has notable limitations. Rapid diagnostic tests (RDTs) have greatly expanded the ability to diagnose malaria due to their simplicity and low cost, but they lack sensitivity and specificity compared to microscopy. Molecular techniques such as polymerase chain reaction (PCR) represent another diagnostic category, each method carrying unique strengths and limitations. Current diagnostics include microscopy, rapid tests, and molecular techniques, all of which contribute to reducing malaria mortality despite their imperfections.
Evolving Diagnostic Technologies
The history of malaria diagnosis has seen a progression of laboratory assays introduced over the years, with each milestone building on previous methods. Polymerase chain reaction (PCR) is a more sophisticated diagnostic method that detects parasite nucleic acids, though it is expensive and less available in endemic zones. Recent advancements in malaria diagnostics have revolutionized detection and management of the disease, with reliable diagnostic tests becoming essential for monitoring drug resistance patterns in malarial parasites.
LAMP Assay: A New Diagnostic Tool
The study’s results indicate that the LAMP assay has a high sensitivity and specificity compared to traditional microscopy. In the prospective arm of the study, LAMP demonstrated a sensitivity of 98.1% (95% CI, 90.0%-100%) and a specificity of 97.6% (95% CI, 95.2%-99.1%) against microscopy. After discrepant resolution using real-time polymerase chain reaction (PCR), the LAMP test achieved 100% sensitivity and specificity.
- Improved Sensitivity: LAMP showed higher sensitivity than RDTs.
- High Specificity: LAMP maintained high specificity, minimizing false positives.
- Reduced Repeat Testing: LAMP’s accuracy could reduce the need for repeat testing.
- Faster Results: LAMP offers quicker turnaround times.
Emerging Diagnostic Approaches
Malaria rapid diagnostic tests (mRDTs) are increasingly used for diagnosis, particularly in communities where microscopy-based diagnosis is not practical. Advanced nanomaterials based on metal, metal oxides, carbon-based, polymeric, lipid-based, and hybrid nanomaterials are being explored for malaria vaccine delivery, vector control, and theranostics. Prompt and accurate diagnosis remains critical to effective malaria management, with current and emerging laboratory techniques assessed for feasibility across both resource-rich and resource-poor settings. Conventional diagnostic methods are being supplemented by recently developed techniques for both malaria detection and infected erythrocyte separation.
Diagnostic Limitations and Diagnostic Gaps
RDTs are very effective for diagnosing malaria, but they cannot determine how many malaria parasites are present in the blood—they can only test whether parasites are present or absent. Falciparum malaria is a life-threatening disease that can cause liver and kidney failure, convulsions, and coma, with symptoms appearing 7 to 30 days after infection in cycles of fever, chills, headache, nausea, and vomiting. In Ethiopia, light microscopy, RDT, PCR, and loop-mediated isothermal amplification (LAMP) have all been identified as malaria diagnostics, each with unique advantages and limitations. When malaria is diagnosed early, treatment outcomes are usually excellent, but delaying treatment can lead to serious health issues including organ failure and death.
Microscopy vs. Rapid Diagnostic Tests
Traditional microscopy remains a cornerstone in malaria diagnosis, as expert microscopists examine stained blood smears to identify and quantify Plasmodium species, offering high specificity and the ability to distinguish between different parasite species. Rapid diagnostic test results have compared well with light microscopy, which is considered the gold standard for laboratory diagnosis of malaria. Peripheral blood smear examination diagnoses malaria by visualizing the parasites within red blood cells, making it a direct detection method.
Implications for Malaria Diagnostics
The study underscores the limitations of traditional malaria diagnostic methods and highlights the potential of the LAMP assay to improve diagnostic accuracy and efficiency. By implementing LAMP, healthcare providers can reduce the need for repeat testing, lower healthcare costs, and provide faster results. This approach ultimately improves patient care and supports malaria elimination efforts in non-endemic regions.
Combining Methods for Better Estimates
The combination of results from two malaria diagnostic methods used in household surveys, together with expert opinion about the performance of the diagnostic methods, offers the possibility to compare prevalence estimates between countries and over time. The most conventional and gold standard test for confirmation of malarial diagnosis is the peripheral blood smear examination. Malaria symptoms vary widely among individuals, often presenting with fever, chills, and flu-like discomfort, making expert-guided diagnosis crucial for early treatment and effective management.
Market Growth and Technological Expansion
The global malaria diagnostics market is witnessing robust growth, driven by increasing malaria prevalence in tropical and subtropical regions and growing awareness regarding early diagnosis. Malaria diagnostics around the world include rapid tests, microscope examinations, and molecular tests like PCR to detect Plasmodium parasites, particularly in areas where malaria is common. The global malaria diagnostics market is projected to reach a valuation of USD 1.2 billion by 2033, growing at a CAGR of 5.8% from 2025 to 2033.
Persistent Diagnostic Challenges
Historically, malaria diagnosis relied heavily on microscopic examination of blood smears, and while advancements have been made, significant challenges remain in diagnostics. Diagnosing malaria during pregnancy is particularly challenging, as parasites sequester in the placenta and cannot be accurately detected by microscopy in the peripheral blood. Several malaria diagnostic techniques have been evaluated for their principle, performance, gaps, accomplishments, and applicability, with existing challenges and future prospects thoroughly discussed in the literature.
Diagnosis in Remote Settings
Malaria is endemic in more than 100 countries, but its rapid and accurate diagnosis in locations remote from clinical laboratory facilities remains challenging yet desperately needed. New evidence on long-term complications of malaria heightens awareness of its public health impact, making the case that proper diagnostic technologies are critical for Africa. Using appropriate diagnostic technologies to improve the quality of malaria diagnosis is essential for reducing the disease's burden on affected populations.